December 14, 2023
Life value
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
VIETNAM AIMING TO BECOME REGIONAL PHARMACEUTICAL PRODUCTION CENTER
Vietnam has set a target of becoming a high-value pharmaceutical production center in the region under its strategy for the development of the pharmaceutical sector by 2030 with a vision to 2045.
Under the strategy, which was approved by Deputy Prime Minister Tran Hong Ha on October 9, Vietnam will strive to develop its pharmaceutical industry to be on par with those in advanced countries in the region while ensuring people’s access to medicines at affordable prices.
It will improve its research capacity and optimize existing technologies to produce generic medicines and modern dosage forms, a part of becoming a center for the technology transfer and manufacture of generic drugs in ASEAN.
Vietnam also targets the mass production of pharmaceuticals and products from domestic medicinal resources with high quality and value, and will boost the production of raw materials.
Other goals under strategy include achieving WHO certification at Level 3 or higher in the capacity of State management over pharmaceutical products, and maintain and upgrade WHO certification on the capacity of State management over vaccines.
All pharmaceutical businesses meeting good manufacturing practice (GMP) standards will be maintained, while all drug and vaccine testing facilities are to follow good laboratory practice (GLP) principles.
Source: https://vneconomy.vn
About STELLAPHARM
Stellapharm is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, antiviral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An City, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com
You May like
28
Oct 2025
STELLAPHARM’S CERTIFIED ISO 14001:2015 (ENVIRONMENTAL MANAGEMENT SYSTEM), ISO 45001:2018 (OCCUPATIONAL HEALTH AND SAFETY MANAGEMENT SYSTEM) COMPLIANCE BY BUREAU VERITAS
Stellapharm J.V. Co., Ltd. – Branch 1 has just been certified by Bureau Veritas Certification – an international certification organization in the field of inspection, testing and certification – compliance with two international standards ISO 14001: 2015 and ISO 45001: 2018 for all pharmaceutical production, distribution and export activities. As a business operating in health
22
Oct 2025
STELLAPHARM ACHIEVED CROATIAN – GMP CERTIFICATION
On July 18, 2025, STELLAPHARM J.V. Co., Ltd. – Branch 1 achieved the EU – GMP (Good Manufacturing Practice) certification issued by the competent authority, the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and the information is published on the EudraGMDP database of the European Union. Achieving this certification not only enhances the